Aim Immunotech Inc (AIM)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE Arca]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE Arca]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 09-2008 | 07-2008 | 06-2008 | 04-2008 | 03-2008 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -9,382 | -470 | -5,967 | -236 | -3,165 |
| Depreciation Amortization | 593 | 311 | 466 | 173 | 126 |
| Income taxes - deferred | N/A | -279 | N/A | -144 | N/A |
| Accounts receivable | 77 | 741 | 74 | -240 | 26 |
| Accounts payable and accrued liabilities | 659 | -507 | 141 | -100 | 15 |
| Other Working Capital | 381 | 311 | -54 | -455 | -2 |
| Other Operating Activity | -178 | -60 | 60 | 466 | 194 |
| Operating Cash Flow | $-7,850 | $47 | $-5,280 | $-536 | $-2,806 |
| Cash Flows From Investing Activities | |||||
| Change In Deposits | N/A | N/A | N/A | N/A | -1,000 |
| PPE Investments | -12 | 24 | N/A | 22 | N/A |
| Sale Of Investment | 3,951 | N/A | 3,951 | N/A | 1,979 |
| Purchase Sale Intangibles | -118 | N/A | N/A | N/A | N/A |
| Other Investing Activity | -118 | 0 | 0 | 0 | 0 |
| Investing Cash Flow | $3,821 | $24 | $3,951 | $22 | $979 |
| Cash Flows From Financing Activities | |||||
| Change In Short Term Borrowing | N/A | 160 | N/A | 669 | N/A |
| Debt Repayment | N/A | -175 | N/A | -88 | N/A |
| Common Stock Issued | 150 | N/A | N/A | N/A | N/A |
| Financing Cash Flow | $150 | $-15 | $N/A | $581 | $N/A |
| Beginning Cash Position | 11,471 | 28 | 11,471 | 28 | 11,471 |
| End Cash Position | 7,592 | 84 | 10,142 | 95 | 9,644 |
| Net Cash Flow | $-3,879 | $56 | $-1,329 | $67 | $-1,827 |
| Free Cash Flow | |||||
| Operating Cash Flow | -7,850 | 47 | -5,280 | -536 | -2,806 |
| Capital Expenditure | -12 | N/A | N/A | N/A | N/A |
| Free Cash Flow | -7,862 | 47 | -5,280 | -536 | -2,806 |